Abstract
Multiparametric MRI in prostate cancer.
Highlights
Imaging has always been problematic in respect to Prostate cancer (PCa) diagnosis and has been essentially limited to biplanar transrectal ultrasound and its modifications
Undersampling, when prostate volume is taken into account, occurs in up to 30% of cases with clinically significant tumors being missed on initial random systematic biopsy [5]
Mp-magnetic resonance imaging (MRI) might be useful in image-guided therapy such as focal therapy, as well as in whole gland therapy such as radical prostatectomy or modern techniques of external beam and interstitial radiotherapy
Summary
Imaging has always been problematic in respect to PCa diagnosis and has been essentially limited to biplanar transrectal ultrasound and its modifications. Random systematic prostate sampling with TRUS guided biopsy has its inherent limitations. Systematic biopsies through random sampling error may lead to incorrect risk stratification and may perform poorly at documenting the exact extent and heterogeneity of the disease [4].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
